Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "H19 long non-coding RNA promoter-driven expression of diphtheria toxin A chain" system leverages tumor-specific transcriptional activity at the lncRNA-H19 locus to selectively induce lethal toxicity through intracellular production of diphtheria toxin's catalytic domain—a strategy designed for precise targeting and elimination of malignant cells that aberrantly express this developmental regulator.
Tumor-selective expression of Diphtheria Toxin A chain, leading to ADP-ribosylation of eEF-2 and inhibition of protein synthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on H19 long non-coding RNA promoter-driven expression of diphtheria toxin A chain (None).